Home> Announcements> International topics> Trilateral Cooperation (JPO-EPO-USPTO)> Trilateral Project 24.1-Biotechnology> Trilateral Project 24.1-Biotechnology 028
Main content starts here.
Yes, on condition that a DNA sequence is clearly defined in a claim by reference to the amino acid sequence of protein X encoded by said DNA sequence, then allelic mutants, derivatives, equivalents or variants of the claimed DNA sequence also fulfill the requirements of clarity provided that the variants etc. of said DNA sequence are additionally all defined as encoding proteins which have the same properties as protein X.